| Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
|---|
| 08/14/2013 | CN103242278A Salt of dimethoxy indolone derivative |
| 08/14/2013 | CN103242277A Preparation method of 2, 3-dideoxyribose, 2, 3-dideoxy-2, 3-didehydroribose and precursor compound thereof |
| 08/14/2013 | CN103242276A Synthesis method of 2, 2-dimethyltetrahydro-2H-pyran-4-carboxylic acid |
| 08/13/2013 | US8507698 Artemisinin derivatives for the treatment of melanoma |
| 08/08/2013 | US20130203843 Mild cationic mitochondrial uncouplers |
| 08/08/2013 | US20130203727 Napht-2-ylacetic acid derivatives to treat aids |
| 08/07/2013 | CN101208352B Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| 08/06/2013 | US8501968 Antitumoral dihydropyran-2-one compounds |
| 08/06/2013 | US8501698 Crystal structures of SGLT2 inhibitors and processes for preparing same |
| 08/06/2013 | CA2563180C Non-nucleoside reverse transcriptase inhibitors |
| 08/01/2013 | US20130197229 Method of making azaindazole derivatives |
| 08/01/2013 | US20130197073 Hypocholesterolemic, anti-inflammatory and antiepileptic neuroprotective compound |
| 08/01/2013 | US20130197072 Method for manufacturing neuraminic acid derivatives |
| 07/31/2013 | CN103228626A Preparation of caprolactone, caprolactam, 2,5-etrahydrofuran-<wbr/>dimethanol, 1,6-<wbr/>hexanediol or 1,2,6-<wbr/>hexanetriol from 5-<wbr/>hydroxymethyl-<wbr/>2-furfuraldehyde |
| 07/31/2013 | CN102807955B Method for preparing anti-tumor compound Rasfonin and special strain of method |
| 07/31/2013 | CN102344427B Synthesis method of glycal |
| 07/30/2013 | US8497385 Bryostatin analogues, synthetic methods and uses |
| 07/30/2013 | US8497301 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 07/25/2013 | WO2013106937A1 3' equatorial-fluorine-substituted neuraminidase inhibitor compounds, compositions and methods for the use thereof as anti-virals |
| 07/25/2013 | WO2013073483A9 Method for producing myo-inositol and myo-inositol derivative |
| 07/25/2013 | WO2012076109A3 2-pyrones |
| 07/25/2013 | US20130190497 Fluorescent substrates for monoamine transporters as optical false neurotransmitters |
| 07/25/2013 | US20130190488 Apoptosis promoters |
| 07/25/2013 | US20130190399 Synthesis and use of omega-3 and omega 6 very long chain polyunsaturated fatty acids (VLC-PUFA) |
| 07/24/2013 | EP2617701A1 Compound having propyl ether as bonding group, liquid crystal composition, and liquid crystal display element |
| 07/24/2013 | CN103214442A 3-substituted alpha-pyrone derivative as well as preparation method and application thereof |
| 07/24/2013 | CN103214376A Substituted 4-aminocyclohexane derivatives |
| 07/24/2013 | CN102112439B 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides |
| 07/23/2013 | CA2542695C Substituted benzylaminoalkylene heterocycles |
| 07/23/2013 | CA2534675C Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 07/18/2013 | WO2013106029A1 Taxane and abeo-taxane analogs |
| 07/18/2013 | US20130184279 N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
| 07/18/2013 | CA2832596A1 Taxane and abeo-taxane analogs |
| 07/11/2013 | WO2013103668A1 Formulations for enhanced bioavailability of zanamivir |
| 07/11/2013 | WO2013063679A9 Use of neu1 sialidase inhibitors in the treatment of cancer |
| 07/11/2013 | US20130178457 Cannabinoid receptor modulators |
| 07/10/2013 | CN103201260A Drug derivatives |
| 07/10/2013 | CN103193745A Alpinia kwangsiensis compound, as well as preparation method and application thereof |
| 07/10/2013 | CN103193744A Method for preparing glycal |
| 07/10/2013 | CN102367244B Preparation method of glucolactone |
| 07/04/2013 | US20130172580 Production of hydroxymethylfurfural from levoglucosenone |
| 07/04/2013 | US20130172579 Process for the production of hexanediols |
| 07/04/2013 | US20130172578 Process for preparing 1, 6-hexanediol |
| 07/04/2013 | US20130171180 Derivatives of glyco-cf2-serine and glyco-cf2-threonine |
| 07/03/2013 | CN103183630A Substituted 4-aminocyclohexane derivatives |
| 07/02/2013 | US8476402 Carbohydrate lactone polymers |
| 06/27/2013 | WO2013096971A1 Asymmetric electrophilic fluorination using an anionic chiral phase-transfer catalyst |
| 06/27/2013 | WO2013093320A1 Novel anti-aging and depigmenting cosmetic compositions |
| 06/27/2013 | WO2013092941A1 BENZYL SULFONAMIDE DERIVATIVES AS RORc MODULATORS |
| 06/27/2013 | US20130165649 Ruthenium complexes for use in olefin metathesis |
| 06/27/2013 | US20130165486 Tetrasubstituted benzenes |
| 06/26/2013 | EP2607360A1 4-isopropyl-6-methoxyphenyl glucitol compound |
| 06/26/2013 | EP2607359A1 Crystal form of 4-isopropylphenyl glucitol compound and process for production thereof |
| 06/26/2013 | EP2606040A1 Agrochemical adjuvants and formulations |
| 06/26/2013 | CN103172604A Lovastatin purification method combining auxiliary magnetic crystallization |
| 06/26/2013 | CN103172603A High-selectivity lovastatin extraction method by esterifying lovastatin acid |
| 06/26/2013 | CN103172602A Lovastatin purification method |
| 06/26/2013 | CN101680008B Hydroxybenzyl or hydroxypyranonemethyl esters as tyrosinase inhibitors |
| 06/25/2013 | US8471045 Synthesis of statins |
| 06/25/2013 | CA2747424C 1-heterodiene derivative and harmful organism control agent |
| 06/25/2013 | CA2557801C Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof |
| 06/20/2013 | WO2013089168A1 Method for producing neuraminic acid derivative |
| 06/20/2013 | WO2013088972A1 Compound and asymmetric synthesis reaction |
| 06/19/2013 | CN103168035A Crystal form of 4-isopropylphenyl glucitol compound and process for production thereof |
| 06/19/2013 | CN102114433B Supported arsine catalyst as well as synthesizing method and application thereof in Wittig reaction |
| 06/19/2013 | CN101575286B Synthesizing method of simvastatin ammonium salt, midbody used thereby and preparation method thereof |
| 06/18/2013 | US8466299 Process for preparing delta-valerolactone in the gas phase |
| 06/18/2013 | US8466298 High selectively polymeric adsorbent based on the hydrogen bonding interaction and the use thereof in isolation and purification of active components from gingko biloba extract |
| 06/13/2013 | WO2013063679A8 Use of neu1 sialidase inhibitors in the treatment of cancer |
| 06/13/2013 | US20130150390 Therapeutic or prophylactic agent for allergic dermatitis |
| 06/12/2013 | EP2601840A2 Chemical and biological agents for the control of molluscs |
| 06/12/2013 | EP2600958A2 Compositions and methods for separating emulsions using the same |
| 06/12/2013 | CN103145666A 4-substituted alpha-pyrone derivative as well as preparation method and application thereof |
| 06/12/2013 | CN102134226B Phenyl C-glucoside derivatives, preparation method and use thereof |
| 06/12/2013 | CN101863766B Beta-hydroxyisovalerylshikonin derivative and preparation method thereof |
| 06/11/2013 | US8460897 Methods of culturing fungi and producing cellulases and chitin |
| 06/06/2013 | WO2013079708A1 2-(substituted-phenyl)-cyclopentane-1,3-dione compounds, and derivatives thereof |
| 06/06/2013 | WO2013079501A1 Crystalline dapagliflozin hydrate |
| 06/06/2013 | CA2857236A1 2-(substituted-phenyl)-cyclopentane-1,3-dione compounds, and derivatives thereof |
| 06/05/2013 | EP2598471A1 Esters of o-substituted hydroxy carboxylic acids and preparations thereof |
| 06/05/2013 | CN103140474A Napht- 2 -ylacetic acid derivatives to treat aids |
| 06/05/2013 | CN103140267A Compositions and methods for separating emulsions using the same |
| 06/05/2013 | CN103130759A Goniothalamus cheliesis vitamin derivative and application of goniothalamus cheliesis vitamin derivative in pharmacy |
| 06/05/2013 | CN101679340B Antitumoral dihydropyran-2-one compounds |
| 05/30/2013 | WO2013075400A1 Liquid crystal compound |
| 05/30/2013 | WO2013054366A8 A. process for the preparation of aminoacrylic acid derivatives |
| 05/29/2013 | EP2597092A1 A process for purification of lovastatin |
| 05/29/2013 | EP2597091A1 Antitumoral Compounds |
| 05/29/2013 | EP2597090A1 Crystalline dapagliflozin hydrate |
| 05/29/2013 | EP2596004A1 Methods for the preparation of diasteromerically pure phosphoramidate prodrugs |
| 05/29/2013 | EP2595980A1 Methods and compounds for treating paramyxoviridae virus infections |
| 05/29/2013 | CN101591266B (3R)-[(2-halo-1-oxooctyl)oxy] tridecyl cyanide and preparation method and application thereof |
| 05/28/2013 | CA2508990C Compounds and methods for the treatment or prevention of flavivirus infections |
| 05/28/2013 | CA2508621C Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 05/23/2013 | WO2013073483A1 Method for producing myo-inositol and myo-inositol derivative |
| 05/23/2013 | WO2012095793A3 (n-alkylcarbamoyl) methyl enulosides and related pyranoside containing an alfa, beta, gama, delta - unsaturated ester, their preparation and their efficacy as antibacterial agents |
| 05/22/2013 | EP2594569A1 Entecavir synthesis method and intermediate compound thereof |
| 05/22/2013 | CN103113339A Maltol separation and purification method |
| 05/22/2013 | CN103113338A Asymmetric full-synthesis method of Tanikolide |
| 05/16/2013 | WO2013070911A1 Compounds and methods for treating cystic fibrosis |